Exome-wide analysis of rare deleterious variants in 3569 sarcoma cases and 21,788 controls from multiple international data sources reveals no novel susceptibility genes.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.